BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23648139)

  • 1. Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer.
    Li XQ; Yang XL; Zhang G; Wu SP; Deng XB; Xiao SJ; Liu QZ; Yao KT; Xiao GH
    J Transl Med; 2013 May; 11():114. PubMed ID: 23648139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
    Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
    Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of differential β-catenin expression with Oct-4 and Nanog in oral squamous cell carcinoma and their correlation with clinicopathological factors and prognosis.
    Ravindran G; Sawant SS; Hague A; Kingsley K; Devaraj H
    Head Neck; 2015 Jul; 37(7):982-93. PubMed ID: 24700702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
    Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
    Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
    Zhang S; Wang Y; Dai SD; Wang EH
    BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC.
    Yuan J; Xing H; Li Y; Song Y; Zhang N; Xie M; Liu J; Xu Y; Shen Y; Wang B; Zhang L; Yang M
    Cancer Lett; 2021 Feb; 499():255-264. PubMed ID: 33242559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC.
    Tseng RC; Huang WR; Lin SF; Wu PC; Hsu HS; Wang YC
    J Cell Mol Med; 2014 Sep; 18(9):1752-61. PubMed ID: 24895061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer.
    Gialmanidis IP; Bravou V; Petrou I; Kourea H; Mathioudakis A; Lilis I; Papadaki H
    Lung; 2013 Oct; 191(5):511-21. PubMed ID: 23864317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery.
    Xu X; Sun PL; Li JZ; Jheon S; Lee CT; Chung JH
    J Thorac Oncol; 2011 Apr; 6(4):716-24. PubMed ID: 21336184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.
    Gao X; Cai Y; Wang Z; He W; Cao S; Xu R; Chen H
    J Transl Med; 2019 Sep; 17(1):308. PubMed ID: 31511014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.
    Chen H; Zhang M; Zhang W; Li Y; Zhu J; Zhang X; Zhao L; Zhu S; Chen B
    Thorac Cancer; 2018 Mar; 9(3):390-399. PubMed ID: 29341468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression.
    Liu L; Yang Y; Liu S; Tao T; Cai J; Wu J; Guan H; Zhu X; He Z; Li J; Song E; Zeng M; Li M
    Oncogene; 2019 Jan; 38(5):747-764. PubMed ID: 30177836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.
    Dai SD; Wang Y; Miao Y; Zhao Y; Zhang Y; Jiang GY; Zhang PX; Yang ZQ; Wang EH
    BMC Cancer; 2009 Jun; 9():178. PubMed ID: 19508730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
    Pelosi G; Scarpa A; Veronesi G; Spaggiari L; Del Curto B; Moore PS; Maisonneuve P; Sonzogni A; Masullo M; Viale G
    Virchows Arch; 2005 Dec; 447(6):969-77. PubMed ID: 16158183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression and cytoplasmic accumulation of Hepl is associated with clinicopathological parameters and poor prognosis in non-small cell lung cancer.
    Miao Y; Wang L; Liu Y; Li AL; Liu SL; Cao HY; Zhang XP; Jiang GY; Liu D; Wang EH
    Tumour Biol; 2013 Feb; 34(1):107-14. PubMed ID: 23001926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
    Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
    J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis.
    Tseng RC; Lin RK; Wen CK; Tseng C; Hsu HS; Hsu WH; Wang YC
    Oncogene; 2008 Jul; 27(32):4488-96. PubMed ID: 18372914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.